Literature DB >> 10498919

Designing dendrimers for drug delivery.

.   

Abstract

Dendrimers are highly branched three-dimensional macromolecules with highly controlled structures, a single molecular weight, a large number of controllable 'peripheral' functionalities and a tendency to adopt a globular shape once a certain size is reached. These features have made their application in pharmaceutical and medicinal chemistry particularly attractive. This review briefly discusses the preparation of dendrimers, their use as gene delivery agents and magnetic resonance imaging agents, and their potential for applications in drug delivery.

Year:  1999        PMID: 10498919     DOI: 10.1016/s1461-5347(99)00203-5

Source DB:  PubMed          Journal:  Pharm Sci Technol Today        ISSN: 1461-5347


  38 in total

1.  Medicine on a small scale.

Authors:  Marijeta Kralj; Kresimir Pavelic
Journal:  EMBO Rep       Date:  2003-11       Impact factor: 8.807

2.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

3.  Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide.

Authors:  Jeanine Giarolla; Kerly Fernanda Mesquita Pasqualoto; Elizabeth I Ferreira
Journal:  Mol Divers       Date:  2013-08-29       Impact factor: 2.943

4.  Electrospun blends of gelatin and gelatin-dendrimer conjugates as a wound-dressing and drug-delivery platform.

Authors:  Alpana A Dongargaonkar; Gary L Bowlin; Hu Yang
Journal:  Biomacromolecules       Date:  2013-10-30       Impact factor: 6.988

Review 5.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

Review 6.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

7.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

8.  A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.

Authors:  Cameron C Lee; Elizabeth R Gillies; Megan E Fox; Steven J Guillaudeu; Jean M J Fréchet; Edward E Dy; Francis C Szoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

9.  Stealth dendrimers for drug delivery: correlation between PEGylation, cytocompatibility, and drug payload.

Authors:  Hu Yang; Stephanie T Lopina; Linda P DiPersio; Steven P Schmidt
Journal:  J Mater Sci Mater Med       Date:  2007-10-19       Impact factor: 3.896

10.  Click hybridization of immune cells and polyamidoamine dendrimers.

Authors:  Leyuan Xu; Olga Yu Zolotarskaya; W Andrew Yeudall; Hu Yang
Journal:  Adv Healthc Mater       Date:  2014-02-13       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.